Literatur
- 1
Burgard P. et al .
Rationale for the German recommendations for phenylalanine level control in phenylketonuria.
Eur J Pediatr.
1999;
158
46-54
- 2
Harris R, Lohr K L.
Screening for prostate cancer: An update of the evidence for the US Preventive Service
Task Force.
Ann Intern Med.
2002;
137
917-929
- 3 http://www.nsc.nhs.uk (accessed 28 February 2003)
- 4
Hillege H L. et al .
Microalbuminuria is common, also in non diabetic, non hypertensive population, and
an independent indicator of cardiovascular risk factors and cardiovascular morbidity.
J Int Med.
2001;
249
519-526
- 5
Mykkänen L. et al .
Microalbuminuria precedes the development of NIDDM.
Diabetes.
1994;
43
552-557
- 6
Schmitz A. et al .
Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.
Diabetologia.
1994;
37
1251-1258
- 7
Nannipieri M. et al .
Transcapillary escape rate of albumin in type 2 diabetic patients. The relationship
with microalbuminuria and hypertension.
Diabetes Care.
1997;
20
1019-1026
- 8
Jager A. et al .
Microalbuminuria is strongly associated with NIDDM and hypertension, but not with
the insulin resistance syndrome: The Hoorn study.
Diabetologia.
1998;
41
694-700
- 9
Fioretto P. et al .
Patterns of renal injury in NIDDM patients with microalbuminuria.
Diabetologia.
1996;
39
1569-1575
- 10
Fioretto P. et al .
Heterogeneous nature of microalbuminuria in NIDDM: study of endothelial function
and renal structure.
Diabetologia.
1998;
41
233-236
- 11
de Grauw W JC. et al .
Microalbuminuria in patients with type 2 diabetes mellitus from general practice:
course and predictive value.
Diabetic Med.
2001;
18
139-143
- 12
Tabei B P. et al .
Does microalbuminuria predict diabetic nephropathy?.
Diabetes Care.
2001;
24
1560-1566
- 13
Trevisan R. et al .
Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline
of kidney function in Type 2 diabetic patients.
Diabetes Care.
2002;
25
2026-2031
- 14
American Diabetes Association .
Diabetic Nephropathy.
Diabetes Care.
2002;
25
(Suppl 1)
S85-S89
- 15
Hovind P. et al .
Progression of diabetic nephropathy.
Kid Int.
2001;
59
702-709
- 16
Rossing P. et al .
Risk factors for development of incipient and overt nephropathy in Type 1 diabetic
patients.
Diabetes Care.
2002;
25
859-864
- 17 SIGN. Management of diabetic nephropathy. http://www.sign.ac.uk/guidelines/fulltext/55/section5.html
(accessed 28 February 2003)
- 18
Ramsay L E. et al .
Guidelines for management of hypertension: report of the third working party of the
British Hypertension Society.
J Hum Hypertens.
1999;
13
569-592
- 19
Kaiser T. et al .
Should blood pressure targets be lower in diabetic patients with microalbuminuria
or nephropathy? A systematic review of randomised controlled trials.
Br J Diab Vasc Dis.
2003;
(in press)
- 20
Sawicki P T, Berger M.
Measuring progression of diabetic nephropathy. Review.
Europ J Clin Invest.
1994;
24
651-655
- 21
Schrier R W. et al .
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients
on albuminuria, retinopathy and strokes.
Kid Int.
2002;
61
1086-1097
- 22
Estacio R O. et al .
Effect of blood pressure control on diabetic microvascular complications in patients
with hypertension and type 2 diabetes.
Diabetes Care.
2000;
23
B54-B64
(Suppl 2)
- 23
Lewis J B. et al .
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy.
Am J Kidney Dis.
1999;
34
809-817
- 24
Parving H H. et al .
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive
type 1 diabetic patients.
Kid Int.
2001;
60
228-234
- 25
Viberti G. et al .
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent
diabetes mellitus and microalbuminuria.
JAMA.
1994;
271
275-279
- 26
Gerstein H C. et al .
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic
and non-diabetic individuals.
JAMA.
2001;
286
421-426
- 27
Hillege H L. et al .
Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality
in general population.
Circulation.
2002;
106
1777-1782
Prof. Dr. med. Peter T. Sawicki
St. Franziskus Hospital
Schönsteinstraße 63
50825 Köln
